Table 6.

Comparison of the incidence of all and major AEs between treatments (iopamidol versus iodixanol)a

AEsTotal (n = 294)Iopamidol Group (n = 145)Iodixanol Group (n = 149)IRR (95% CI)Pb
All events1.8 (1.1 to 3.0)0.016
    patients with events (n [%])92 (31%)39 (27%)53 (36%)
    no. of events1204872
    person-time of follow-up (yr)387198189
Major eventsc3.2 (1.2 to 8.9)0.024
    patients with events (n [%])38 (13%)16 (11%)22 (15%)
    no. of major events451728
    person-time of follow-up (yr)387198189
  • a IRR comparing iodixanol and iopamidol from Poisson regression model.

  • b P value from Poisson regression analysis.

  • c Major events: Death, stroke, myocardial infarction, and ESRD requiring dialysis.